BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 17549484)

  • 41. Preresection Radiologic Assessment and Imaging Features of 156 Pathologically Proven Adrenal Adenomas.
    Elsherif SB; Javadi S; Blair KJ; Morshid AI; Hui L; Khalaf AM; Elbanan MG; Zhang M; Habra MA; Elsayes KM
    J Comput Assist Tomogr; 2020; 44(3):419-425. PubMed ID: 32345808
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The washout rate on the delayed CT image as a diagnostic tool for adrenal adenoma verified by pathology: a multicenter study.
    Park SW; Kim TN; Yoon JH; Kim TH; Chung JM; Jeon UB; Lee W
    Int Urol Nephrol; 2012 Oct; 44(5):1397-402. PubMed ID: 22798018
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Differentiation of malignant from benign pheochromocytomas with diffusion-weighted and dynamic contrast-enhanced magnetic resonance at 3.0 T.
    Dong Y; Liu Q
    J Comput Assist Tomogr; 2012; 36(4):361-6. PubMed ID: 22805661
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Incidental adrenal lesions detected on enhanced abdominal dual-energy CT: can the diagnostic workup be shortened by the implementation of virtual unenhanced images?
    Botsikas D; Triponez F; Boudabbous S; Hansen C; Becker CD; Montet X
    Eur J Radiol; 2014 Oct; 83(10):1746-51. PubMed ID: 25064663
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Unenhanced CT imaging is highly sensitive to exclude pheochromocytoma: a multicenter study.
    Buitenwerf E; Korteweg T; Visser A; Haag CMSC; Feelders RA; Timmers HJLM; Canu L; Haak HR; Bisschop PHLT; Eekhoff EMW; Corssmit EPM; Krak NC; Rasenberg E; van den Bergh J; Stoker J; Greuter MJW; Dullaart RPF; Links TP; Kerstens MN
    Eur J Endocrinol; 2018 May; 178(5):431-437. PubMed ID: 29467230
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Adrenal mass imaging with multidetector CT: pathologic conditions, pearls, and pitfalls.
    Johnson PT; Horton KM; Fishman EK
    Radiographics; 2009; 29(5):1333-51. PubMed ID: 19755599
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Differentiating pheochromocytoma from lipid-poor adrenocortical adenoma by CT texture analysis: feasibility study.
    Zhang GM; Shi B; Sun H; Jin ZY; Xue HD
    Abdom Radiol (NY); 2017 Sep; 42(9):2305-2313. PubMed ID: 28357529
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Incidental adrenal lesions: Accuracy of quadriphasic contrast enhanced computed tomography in distinguishing adenomas from nonadenomas.
    Foti G; Faccioli N; Mantovani W; Malleo G; Manfredi R; Mucelli RP
    Eur J Radiol; 2012 Aug; 81(8):1742-50. PubMed ID: 21602008
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Pheochromocytomas: detection with 11C hydroxyephedrine PET.
    Trampal C; Engler H; Juhlin C; Bergström M; Långström B
    Radiology; 2004 Feb; 230(2):423-8. PubMed ID: 14752186
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Chemical-shift MRI versus washout CT for characterizing adrenal incidentalomas.
    Warda MH; Shehata SM; Zaiton F
    Clin Imaging; 2016; 40(4):780-7. PubMed ID: 27317224
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Distinguishing adrenal adenomas from non-adenomas on dynamic enhanced CT: a comparison of 5 and 10 min delays after intravenous contrast medium injection.
    Kumagae Y; Fukukura Y; Takumi K; Shindo T; Tateyama A; Kamiyama T; Kamimura K; Nakajo M
    Clin Radiol; 2013 Jul; 68(7):696-703. PubMed ID: 23482305
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Differential diagnosis of space-occupying adrenal masses].
    Szolar DH; Unger B; Heinz-Peer G; Preidler K; Ranner G
    Rofo; 1999 Oct; 171(4):269-78. PubMed ID: 10598161
    [TBL] [Abstract][Full Text] [Related]  

  • 53. CT features and quantification of the characteristics of adrenocortical carcinomas on unenhanced and contrast-enhanced studies.
    Zhang HM; Perrier ND; Grubbs EG; Sircar K; Ye ZX; Lee JE; Ng CS
    Clin Radiol; 2012 Jan; 67(1):38-46. PubMed ID: 21783181
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Comparison of delayed enhanced CT and 18F-FDG PET/CT in the evaluation of adrenal masses in oncology patients.
    Park BK; Kim CK; Kim B; Choi JY
    J Comput Assist Tomogr; 2007; 31(4):550-6. PubMed ID: 17882030
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Differentiation between tuberculosis and primary tumors in the adrenal gland: evaluation with contrast-enhanced CT.
    Yang ZG; Guo YK; Li Y; Min PQ; Yu JQ; Ma ES
    Eur Radiol; 2006 Sep; 16(9):2031-6. PubMed ID: 16435135
    [TBL] [Abstract][Full Text] [Related]  

  • 56. CT time-attenuation washout curves of adrenal adenomas and nonadenomas.
    Korobkin M; Brodeur FJ; Francis IR; Quint LE; Dunnick NR; Londy F
    AJR Am J Roentgenol; 1998 Mar; 170(3):747-52. PubMed ID: 9490968
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Comparison of computed tomographic and pathologic findings in 17 dogs with primary adrenal neoplasia.
    Gregori T; Mantis P; Benigni L; Priestnall SL; Lamb CR
    Vet Radiol Ultrasound; 2015; 56(2):153-9. PubMed ID: 25139015
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Basal cell adenoma and myoepithelioma of the parotid gland: patterns of enhancement at two-phase CT in comparison with Warthin tumor.
    Lee JY; Kim HJ; Kim YK; Cha J; Kim ST
    Diagn Interv Radiol; 2019 Jul; 25(4):285-290. PubMed ID: 31120425
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Imaging methods in diagnosis of pheochromocytoma].
    Neumann K; Langer R
    Zentralbl Chir; 1997; 122(6):438-42. PubMed ID: 9334109
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Differentiation of Adrenal Hyperplasia From Adenoma by Use of CT Densitometry and Percentage Washout.
    Park SY; Park BK; Park JJ; Kim CK
    AJR Am J Roentgenol; 2016 Jan; 206(1):106-12. PubMed ID: 26700341
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.